Cabergoline and blood creatine phosphokinase increased Patient Reports February 12, 2012

Cabergoline Side Effects Report #4645531-4
Cabergoline side effect was reported by a Pharmacist from on Apr 13, 2005. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with parkinson's disease , toothache and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, fall . Cabergoline dosage: unknown. During the same period patient was treated with BUFFERIN, AMLODIPINE BESYLATE, SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4655902-8
Cabergoline side effect was reported by a Pharmacist from on Apr 22, 2005. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with parkinson's disease , toothache and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, depressed level of consciousness, fall , incoherent, pyrexia, toothache, white blood cell count increased. Cabergoline dosage: unknown. During the same period patient was treated with BUFFERIN, AMLODIPINE BESYLATE, SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5304905-9
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on Apr 11, 2007. Male patient, 71 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac failure, cardiac valve disease, constipation , dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, neuroleptic malignant syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4551652-7
Cabergoline side effect was reported by a Health Professional from on Dec 28, 2004. Male patient, 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cerebral haemorrhage traumatic, contusion, fall , gait disturbance, hypokinesia, masked facies, muscle rigidity, myoglobin blood increased. Cabergoline dosage: 0.25 MG (0.25 MG 1 IN 1 D ) ORAL. During the same period patient was treated with MADOPAR, BENIDIPINE HYDROCHLORIDE, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4579808-8
Cabergoline side effect was reported by a Consumer or non-health professional from on Jan 31, 2005. Male patient, 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cerebral haemorrhage traumatic, contusion, fall , flat affect, gait disturbance, hypokinesia, muscle rigidity, myoglobin blood increased. Cabergoline dosage: 0.25 MG (0.25 MG 1 IN 1D ) ORAL. During the same period patient was treated with MADOPAR, BENIDIPINE HYDROCHLORIDE, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5082099-5
Cabergoline side effect was reported by a Physician from GERMANY on July 31, 2006. Male patient, 70 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: accidental overdose, ascites, blood creatine phosphokinase increased, c-reactive protein increased, dyskinesia, pyrexia, somnolence. Cabergoline dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, DIPYRONE, TRAMADOL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4639512-4
Cabergoline side effect was reported by a Pharmacist from on Apr 05, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fall . Cabergoline dosage: 2.5 MG (2.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SINEMET, ASPIRIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4562657-4
Cabergoline side effect was reported by a Physician from on Jan 12, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, dysphagia, fall , grand mal convulsion, hallucination, hepatic function abnormal, mobility decreased. Cabergoline dosage: 0.25 MG, ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, MAPROTILINE, SINEMET, AMANTADINE, FUROSEMIDE, SPIRONOLACTONE, ETIZOLAM. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4680707-1
Cabergoline side effect was reported by a Physician from on May 19, 2005. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood triglycerides increased, muscle swelling, oedema peripheral. Cabergoline dosage: unknown. During the same period patient was treated with SIFROL, LEVODOPA, PERMAX, EPADEL, DEPAS. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4692177-8
Cabergoline side effect was reported by a Physician from on June 01, 2005. Male patient, 67 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood triglycerides increased, hypothyroidism, muscle swelling, muscular dystrophy , oedema peripheral. Cabergoline dosage: unknown. During the same period patient was treated with SIFROL, CARBIDOPA, PERMAX, EPADEL, DEPAS. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5356927-X
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, weighting 101.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac valve disease, constipation , dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, parkinson's disease , pyrexia. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE, MADOPAR, SEROQUEL, THYRADIN S, GASTER, LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5080135-3
Cabergoline side effect was reported by a Pharmacist from UNITED KINGDOM on July 31, 2006. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Cabergoline dosage: 8 MG (4 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #4774991-3
Cabergoline side effect was reported by a Physician from GERMANY on Sept 08, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis, anaemia, aortic valve incompetence, arterial fibrosis, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchial obstruction. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4785374-4
Cabergoline side effect was reported by a Physician from GERMANY on Sept 20, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alveolitis, anaemia, aortic valve incompetence, arterial fibrosis, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchial obstruction. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4845421-8
Cabergoline side effect was reported by a Pharmacist from JAPAN on Nov 17, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, neuroleptic malignant syndrome, shock, tremor. Cabergoline dosage: unknown. During the same period patient was treated with SETIPTILINE, FLUVOXAMINE MALEATE, DROXIDOPA, LEVODOPA, BROMOCRIPTINE MESYLATE, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4942887-X
Cabergoline side effect was reported by a Pharmacist from JAPAN on Feb 28, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fatigue. Cabergoline dosage: 1.5 MG ORAL. During the same period patient was treated with MENESIT, NAUZELIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4971592-9
Cabergoline side effect was reported by a Health Professional from JAPAN on Mar 29, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fatigue. Cabergoline dosage: 1.5 MG; ORAL. During the same period patient was treated with MENESIT, NAUZELIN. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4985759-7
Cabergoline side effect was reported by a Physician from JAPAN on Apr 10, 2006. Female patient, 62 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abnormal behaviour, affect lability, agitation, akinesia, amnesia, blood creatine phosphokinase increased, bradyphrenia, catatonia, condition aggravated. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with SELEGILINE, ZONISAMIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4750076-7
Cabergoline side effect was reported by a Pharmacist from JAPAN on Aug 08, 2005. Male patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle spasms. Cabergoline dosage: unknown. Patient recovered.


Cabergoline Side Effects Report #5354757-6
Cabergoline side effect was reported by a Physician from BRAZIL on May 31, 2007. Male patient, 28 years of age, was diagnosed with hyperprolactinaemia and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.